Oxford AstraZeneca vaccine shows promise in protecting people with HIV

The Wits Vaccines and Infectious Diseases Analytical (VIDA) research unit conducted the phase 1B/2A clinical trial. The findings, published in The Lancet HIV on 17 August 2021, show that the AstraZeneca COVID-19 vaccine is likely to work as well in people living with HIV compared with people who are HIV negative.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca